Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 14, 2014 - Issue 1
Submit an article Journal homepage
481
Views
19
CrossRef citations to date
0
Altmetric
Reviews

The value of procalcitonin measurement in localized skin and skin structure infection, diabetic foot infections, septic arthritis and osteomyelitis

Kordo SaeedMicrobiology Department, Hampshire Hospitals NHS Foundation Trust, Royal Hampshire County Hospital, Winchester, UKCorrespondence[email protected]
,
Nusreen AhmadPublic Health England and Southampton University, Hospitals NHS Foundation Trust, Southampton, UK
&
Matthew DrydenMicrobiology Department, Hampshire Hospitals NHS Foundation Trust, Royal Hampshire County Hospital, Winchester, UK
Pages 47-54 | Published online: 02 Dec 2013

References

  • Gendrel D, Raymond J, Coste J et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr. Infect. Dis. J. 18(10), 875–881 (1999).
  • Christ-Crain M, Müller B. Procalcitonin in bacterial infections—hype, hope, more or less? Swiss Med. Wkly 135, 451–460 (2005).
  • Giamarellos-Bourboulis EJ, Mega A, Grecka P. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med. 28, 1351–1356 (2002).
  • Chalupa P, Beran O, Herwald H et al. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 39(5), 411–417 (2011).
  • Lipinska-Gediga M, Mierzchala M, Durek G. Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance. Infection 40(3), 303–309 (2012).
  • Harbarth S, Albrich WC, Muller B. When once is not enough--further evidence of procalcitonin-guided antibiotic stewardship. Crit. Care 13(4), 165 (2009).
  • Hochreiter M, Schroeder S. Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients. Der. Anaesthesist. 60, 661–673 (2011).
  • Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 9, 107 (2011).
  • Nobre V, Harbarth S, Graf JD et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am. J. Respir. Crit. Care Med. 177, 498–505 (2008).
  • Saeed K, Dryden M, Bourne S et al. Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection. J. Hosp. Infect. 78, 289–292 (2011).
  • Wilcox MH, Corey GR, Talbot GH et al. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J. Antimicrob. Chemother. 65(Suppl. 4), iv53–iv65 (2010).
  • Eder J, Hlavin G, Haushofer A et al. Correlation of serum procalcitonin with the severity of skin and skin structure infections – a pilot study. JDDG 10, 564–570 (2012).
  • Cavanagh PR, Lipsky BA, Bradbury AW et al. Treatment for diabetic foot ulcers. Lancet 366, 1725–1735 (2005).
  • Byren I, Peters EJ, Hoey C et al. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin. Pharmacother. 10(18), 3033–3047 (2009).
  • Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 293(2), 217–228 (2005).
  • Oyibo SO, Jude EB, Tarawneh I et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet. Med. 18(2), 133–138 (2001).
  • Williams DT, Hilton JR, Harding KG. Diagnosing foot infection in diabetes. Clin. Infect. Dis. 39(suppl 2), S83–S86 (2004).
  • Eneroth M, Larsson J, Apelqvist J. Deep foot infections in patients with diabetes and foot ulcers: an entity with different characteristics, treatments, and prognosis. J. Diabetes Complications 13, 254–263 (1999).
  • Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J. Am. Podiatr. Med. Assoc. 86, 224–227 (1996).
  • Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int. 18, 716–722 (1997).
  • Uzun G, Solmazgul E, Curuksulu H et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J. Exp. Med. 213, 305–312 (2007).
  • Lipsky BA.. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab. Res. Rev. 20(Suppl. 1), S68–S77 (2004).
  • Talebi-Taher M, Moradi S, Azizi MR, Shekarabi M, Barati M. Procalcitonin in diagnosing the diabetic foot infection. Iran J. Clin. Infect. Dis. 6, 71–73 (2011).
  • Jeandrot A, Richard JL, Combescure C et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 51, 347–352 (2008).
  • Altay FA, Sencan İ, Şentürk GÇ, Altay M, Güvenman S, Ünverdi S, Açıkgöz ZC. Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study. J. Diabetes Complications 26, 214–218 (2012).
  • Mutluoğlu M, Uzun G, İpcioğlu OM et al. Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study. Diabetes Res. Clin. Pract. 94, 53–56 (2011).
  • American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 22(8), 1354–1360 (1999).
  • Ertugrul BM, Savk O, Ozturk B, Cobanoglu M, Oncu S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med. Sci. Monit. 15(6), CR307–CR312 (2009).
  • Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA 297, 1478–1488 (2007).
  • Saeed K. Diagnosis of Prosthetic joint infections. J. Antimicrob. Chemother. Suppl. (2013) (In Press).
  • Soderquist B, Jones I, Fredlund H et al. Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand. J. Infect. Dis. 30(6), 591–596 (1998).
  • Martinot M, Sordet C, Soubrier M et al. Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients. Clin. Exp. Rheumatol. 23(3), 303–310 (2005).
  • Streit G, Alber D, Toubin M, Toussirot E, Wendling D. Procalcitonin, C-reactive protein, and complement-3a assays in synovial fluid for diagnosing septic arthritis: preliminary results. Joint Bone Spine. 75, 238–239 (2008).
  • Fottner A, Birkenmaier C, von Schulze Pellengahr C et al. Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy 24(2), 229–233 (2008).
  • Hügle T, Schuetz P, Mueller B et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin. Exp. Rheumatol. 26(3), 453–456 (2008).
  • Talebi-Taher M, Shirani F, Nikanjam N, Shekarabi M. Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers. Rheumatol. Int. 33, 319–324 (2013).
  • Saeed K, Dryden M, Sitjar A, White G. Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening. Infection 41(4), 845–849 (2013).
  • Butbul-Aviel Y, Koren A, Halevy R et al. Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr. Emerg. Care 21(12), 828–832 (2005).
  • Faesch S, Cojocaru B, Hennequin C et al. Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial. Ital. J. Pediatr. 35(1), 1–6 (2009).
  • Greeff E. Is procalcitonin useful in diagnosing septic arthritis and osteomyelitis in children? SA Orth. J. 11, 52–56 (2012).
  • Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Gotze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J. Bone Joint Surg. Br. 89, 94–99 (2007).
  • Worthington T, Dunlop D, Casey A et al. Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision. Br. J. Biomed. Sci. 67, 71–76 (2010).
  • Drago L, Vassena C, Dozio E et al. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int. J. Immunopathol. Pharmacol. 24(2), 433–440 (2011).
  • Randau T, Wimmer M, Kuberra D et al. Detection of periprosthetic joint infections: Blood infection markers in patients undergoing revision arthroplasty. Eur. Cell. Mater. 21 (Suppl. 2), 36 (2011).
  • Jaime A. Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. J. Antimicrob. Chemother. 67(11), 2560–2569 (2012).
  • Chan T, Gu F. Early diagnosis of sepsis using serum biomarkers. Expert Rev. Mol. Diagn. 11(5), 487–496 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.